SUBSTIPHARM
Marc Vouillamoz is an accomplished professional in the biotechnology and pharmaceuticals industry, currently serving as the Head of Industrial Affairs - Biologics Operations at SUBSTIPHARM since July 2023. Previously, Marc held significant leadership roles, including Vice President of Manufacturing Operations at KBI Biopharma, Director of Operations at ADOCIA, and General Manager - Site Head at LFB Biomanufacturing. Marc has extensive experience in manufacturing processes, supply chain management, and ensuring compliance with Good Manufacturing Practices (GMP). A strong educational background includes an MBA from HEG-Arc and a Bachelor's degree in Biotechnology. Marc's expertise encompasses quality assurance, manufacturing optimization, and the successful launch of biotech facilities, underscoring a commitment to driving operational excellence and innovation in the industry.
This person is not in any offices
SUBSTIPHARM
Substipharm is a privately held pharmaceutical Group. We develop, supply and commercialize pharmaceuticals in more than 60 countries worldwide. Our portfolio of products that we currently license out or distribute directly or through partners comprises more than 60 different molecules. Our development pipeline includes as well more than 40 ongoing projects. We have a successful portfolio of pharmaceutical products and vaccines including: Mature brands Generics Over the counter (OTC) pharmaceuticals Difficult to develop medicines Value added presentations Biological products including vaccines: